rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ESPR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure

      – Loop Diuretic Route of Administration Option Is Delivered As A Single-Use Nasal Spray – – Nasal Route Offers a Direct Path to Systemic Absorption Without Relying on the GI Tract – ANN ARBOR, Mich., Sept. 30, 2026 (GLOBE NEWSWIRE) -- With more than six million Americans living with heart failure and healthcare systems increasingly focused on delivering care beyond traditional care settings, Esperion, a company wholly-owned by ARCHIMED, is launching a nationwide effort to raise awareness of ENBU

      Sep 30Yahoo FinanceESPR

      This is the newest page. Registered accounts read further back.